Dec 2022
![brightech international logo](https://s33007.pcdn.co/wp-content/uploads/2022/12/brightech-international.png)
Acquired by Everest Clinical Research, a Portfolio Company of Arlington Capital Partners
Exclusive Financial Advisor
View Details >Apr 2022
$225 Million
![](https://s33007.pcdn.co/wp-content/uploads/2020/02/Establishment-Labs.jpg)
Our primary goals as an organization are achieved through adhering to our core values of vision, empathy, sustainability and tenacious teamwork in pursuit of our clients’ interests.
Acquired by Everest Clinical Research, a Portfolio Company of Arlington Capital Partners
Exclusive Financial Advisor
View Details >